News & Updates

Blood pressure (BP) slightly decreases in patients with obstructive sleep apnoea who undergo continuous positive airway pressure (CPAP) therapy, as seen in a study. Such effect is marginally higher in those with above-average apnea-hypopnea index (AHI).

Application of the modified Alpha stent, an intracranial closed-cell stent with a unique mesh design, delivers satisfactory outcomes in coil embolization of unruptured distal internal carotid artery (ICA) aneurysms, reports a study. Its recent adjustment facilitates a less complicated delivery and deployment.

The use of bempedoic acid helps lower low-density lipoprotein cholesterol (LDL-C) levels and subsequently reduce cardiovascular events in individuals at high cardiovascular risk, according to the CLEAR* Outcomes trial.

Monthly administration of olezarsen 50 or 80 mg significantly reduced triglyceride levels in patients with predominantly moderate hypertriglyceridemia (HTG) and elevated cardiovascular (CV) risk, according to the Bridge-TIMI 73a trial presented at ACC.24.

Elevated nonhigh-density lipoprotein cholesterol (non–HDL-C) levels in childhood that persist into adulthood poses an increased risk of cardiovascular disease (CVD), according to a study. But the good news is that the resolution of dyslipidaemic non–HDL-C levels adulthood may help prevent CVD events.

A second pre-eclampsia does not lead to worse outcomes relative to the first occurrence, suggests a study. On the contrary, some clinical features and effects appear to be better in the second event.